Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06836557 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis

Name: Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis — clinical trial record (NCT06836557)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 3

SponsorVanda Pharmaceuticals

Started2024-01-09

View on ClinicalTrials.gov ↗

Record status

This record was last updated February 20, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Vanda Pharmaceuticals

23 trials monitored

See 3 trials at risk

This is a multicenter, open label, 3-month safety study with tradipitant in patients with idiopathic and diabetic gastroparesis.

Trial Details

NCT Number	NCT06836557
Lead Sponsor	Vanda Pharmaceuticals
Conditions	Idiopathic Gastroparesis, Diabetic Gastroparesis, Gastroparesis
Enrollment	100 participants
Start Date	2024-01-09
Primary Completion	2025-12 (estimated)
Study Completion	2025-12 (estimated)
Updated on ClinicalTrials.gov	2025-02-20